51202404 Canakinumab

Definition

UNSPSC 51202404

This classification denotes a monoclonal antibody with the molecular formula C6452H9958N1722O2010S42, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 37CQ2C7X93, more generally known as canakinumab. European Medicines Agency schedules canakinumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30137. The term CANAKINUMAB is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 22, No. 1, 2008, list 59. As of Q4 2014, CANAKINUMAB remains US FDA's Preferred Term for this commodity.

Same parent

Under 51202400 · 21

51202401 Adalimumab Commodity 51202402 Basiliximab Commodity 51202403 Belimumab Commodity 51202404 Canakinumab You are here 51202405 Certolizumab Commodity 51202406 Certolizumab pegol Commodity 51202407 Dacliximab or daclizumab Commodity 51202408 Eculizumab Commodity 51202409 Infliximab Commodity 51202410 Muromonab cd3 Commodity 51202411 Natalizumab Commodity 51202412 Omalizumab Commodity 51202413 Secukinumab Commodity 51202414 Ustekinumab Commodity 51202415 Ramucirumab Commodity 51202416 Daratumumab Commodity 51202417 Golimumab Commodity 51202418 Siltuximab Commodity 51202419 Dinutuximab Commodity 51202420 Polygala fluid extract Commodity 51202421 Thymalfasin Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51200000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class